Rick Davis
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Treatment of Major Depression
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacology and Obesity Treatment 2
-
- Blood Pressure and Hypertension Studies 3
- Co-authors
- Harriet M. Bryson (3 shared papers)Anthony Markham (2 shared papers)Julia A. Balfour (1 shared paper)Donna McTavish (4 shared papers)Ruth Whittington (2 shared papers)David H. Peters (1 shared paper)Michelle I. Wilde (2 shared papers)Diana Faulds (2 shared papers)
- Journals
- Drugs (8 papers)PharmacoEconomics (3 papers)CNS Drugs (2 papers)Disease Management & Health Outcomes (2 papers)Drugs & Aging (2 papers)
- Partner nations
- United StatesNew ZealandAustralia
In The Last Decade
Rick Davis
22 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 120
- Molecular Medicine 140
- Pharmacology 442
- Psychiatry and Mental health 287
- Pediatrics, Perinatology and Child Health 255
- Biological Psychiatry 27
Countries citing papers authored by Rick Davis
This map shows the geographic impact of Rick Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Davis more than expected).
Fields of papers citing papers by Rick Davis
This network shows the impact of papers produced by Rick Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Davis. The network helps show where Rick Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Rick Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 346 | |
| 2 | 1994 | 301 | |
| 3 | Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. | 1994 | 243 |
| 4 | 1997 | 121 | |
| 5 | 1997 | 119 | |
| 6 | 1996 | 110 | |
| 7 | 1995 | 87 | |
| 8 | 1996 | 85 | |
| 9 | 1996 | 30 | |
| 10 | 1997 | 27 | |
| 11 | 1996 | 21 | |
| 12 | 1997 | 20 | |
| 13 | 1997 | 17 | |
| 14 | 1994 | 15 | |
| 15 | 1995 | 13 | |
| 16 | 2023 | 12 | |
| 17 | 1995 | 11 | |
| 18 | 1995 | 7 | |
| 19 | 2016 | 5 | |
| 20 | 1997 | 3 |
About Rick Davis
Rick Davis is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Psychiatry and Mental health, Surgery and Physiology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Electroconvulsive Therapy Studies (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Pneumonia and Respiratory Infections (2 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Molecular Medicine (140 citations), Pharmacology (442 citations), Psychiatry and Mental health (287 citations), Pediatrics, Perinatology and Child Health (255 citations) and Biological Psychiatry (27 citations). Rick Davis has collaborated with scholars based in United States, New Zealand and Australia. Frequent co-authors include Harriet M. Bryson, Anthony Markham, Julia A. Balfour, Donna McTavish, Ruth Whittington, David H. Peters, Michelle I. Wilde, Diana Faulds, Heather D. Langtry and Jane C. Gillis. Their work appears in journals such as Drugs, PharmacoEconomics, CNS Drugs, Disease Management & Health Outcomes and Drugs & Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.